Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAGLIFLOZIN Cause Drug ineffective? 569 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 569 reports of Drug ineffective have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 2.3% of all adverse event reports for CANAGLIFLOZIN.

569
Reports of Drug ineffective with CANAGLIFLOZIN
2.3%
of all CANAGLIFLOZIN reports
3
Deaths
56
Hospitalizations

How Dangerous Is Drug ineffective From CANAGLIFLOZIN?

Of the 569 reports, 3 (0.5%) resulted in death, 56 (9.8%) required hospitalization, and 8 (1.4%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 569 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,413) Toe amputation (2,193) Osteomyelitis (2,146) Acute kidney injury (1,853) Fungal infection (1,385) Gangrene (1,081) Weight decreased (1,014) Cellulitis (1,007) Urinary tract infection (920) Diabetic foot infection (832)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which CANAGLIFLOZIN Alternatives Have Lower Drug ineffective Risk?

CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN CANAGLIFLOZIN vs CANAKINUMAB CANAGLIFLOZIN vs CANDESARTAN CANAGLIFLOZIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE

Related Pages

CANAGLIFLOZIN Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective CANAGLIFLOZIN Demographics